EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
3.2.1.31 | (1S)-1-(chloromethyl)-3-([5-[2-(dimethylamino)ethoxy]-1H-indol-2-yl]carbonyl)-2,3-dihydro-1H-benzo[e]indol-5-yl beta-D-glucopyranosiduronic acid + H2O |
- |
Homo sapiens |
D-glucuronate + [(1S)-1-(chloromethyl)-5-hydroxy-1,2-dihydro-3H-benzo[e]indol-3-yl][5-[2-(dimethylamino)ethoxy]-1H-indol-2-yl]methanone |
- |
? |
3.2.1.31 | (1S,3S)-3,12-dihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-{[({2-[({[4-(beta-D-glucopyranuronosyloxy)-3-nitrobenzyl]oxy}carbonyl)amino]-5-({[(2-{[4-({[(pyridin-3-ylmethoxy)carbonyl]amino}methyl)benzoyl]amino}phenyl)carbamoyl]oxy}methyl)benzyl}oxy)carbonyl]amino}-alpha-D-lyxo-hexopyranoside + H2O |
- |
Homo sapiens |
D-glucuronate + (1S,3S)-3,12-dihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-[({[2-({[(4-hydroxy-3-nitrobenzyl)oxy]carbonyl}amino)-5-({[(2-{[4-({[(pyridin-3-ylmethoxy)carbonyl]amino}methyl)benzoyl]amino}phenyl)carbamoyl]oxy}methyl)benzyl]oxy}carbonyl)amino]-alpha-D-lyxo-hexopyranoside |
- |
? |
3.2.1.31 | (4GlcAbeta1-3GalNAc(4-OSO3-)beta1-)2 + H2O |
no activity with enzyme acting on chondroitin, 142% of the activity with (4GlcAbeta1-3GlcNAc1-)2 with the enzyme acting on p-nitrophenyl-beta-D-glucuronide |
Oryctolagus cuniculus |
D-glucuronate + ? |
- |
? |
3.2.1.31 | (4GlcAbeta1-3GalNAc(4-OSO3-)beta1-)3 + H2O |
no activity with enzyme acting on chondroitin, 63% of the activity with (4GlcAbeta1-3GlcNAc1-)2 with the enzyme acting on p-nitrophenyl-beta-D-glucuronide |
Oryctolagus cuniculus |
D-glucuronate + ? |
- |
? |
3.2.1.31 | (4GlcAbeta1-3GalNAc(6-OSO3-)beta1-)2 + H2O |
no activity with enzyme acting on chondroitin, 50% of the activity with (4GlcAbeta1-3GlcNAc1-)2 with the enzyme acting on p-nitrophenyl-beta-D-glucuronide |
Oryctolagus cuniculus |
D-glucuronate + ? |
- |
? |
3.2.1.31 | (4GlcAbeta1-3GalNAc(6-OSO3-)beta1-)3 + H2O |
no activity with enzyme acting on chondroitin, 33% of the activity with (4GlcAbeta1-3GlcNAc1-)2 with the enzyme acting on p-nitrophenyl-beta-D-glucuronide |
Oryctolagus cuniculus |
D-glucuronate + ? |
- |
? |
3.2.1.31 | (4GlcAbeta1-3GalNAcbeta1-)2 + H2O |
66% of the activity with (4GlcAbeta1-3GlcNAc1-)2 with the enzyme acting on chondroitin, 90% of the activity with (4GlcAbeta1-3GlcNAc1-)2 with the enzyme acting on p-nitrophenyl-beta-D-glucuronide |
Oryctolagus cuniculus |
D-glucuronate + ? |
- |
? |
3.2.1.31 | (4GlcAbeta1-3GalNAcbeta1-)3 + H2O |
56% of the activity with (4GlcAbeta1-3GlcNAc1-)2 with the enzyme acting on chondroitin, 71% of the activity with (4GlcAbeta1-3GlcNAc1-)2 with the enzyme acting on p-nitrophenyl-beta-D-glucuronide |
Oryctolagus cuniculus |
D-glucuronate + ? |
- |
? |
3.2.1.31 | (4GlcAbeta1-3GlcNAcbeta1-)3 + H2O |
81% of the activity with (4GlcAbeta1-3GlcNAc1-)2 with the enzyme acting on chondroitin, 73% of the activity with (4GlcAbeta1-3GlcNAc1-)2 with the enzyme acting on p-nitrophenyl-beta-D-glucuronide |
Oryctolagus cuniculus |
D-glucuronate + ? |
- |
? |
3.2.1.31 | 1-deoxy-1-(6-thiopurinyl)-beta-D-glucopyranoside + H2O |
- |
Bos taurus |
6-mercaptopurine + D-glucopyranose |
- |
? |